25G Huber Needle
Martech Medical Products · Decision date Sep 18, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision for K254095, the 25G Huber Needle submitted by Martech Medical Products of Harleysville, Pennsylvania, with a decision date of September 18, 2026. The device is a hypodermic non-coring right-angle needle with an LDPE protective tube, a female luer-lock connected through an extension, an in-line clamp, a gauge ID tag and winged hub, classified under 21 CFR 880.5570 as a Class II hypodermic single lumen needle, product code PTI, in the General Hospital panel.
The submission is a traditional 510(k), not third-party reviewed and not a combination product, so SESE reflects clearance rather than PMA approval. The stated predicate is the Huber Needle Infusion Set (K200463), cleared April 7, 2021, held by Jiangsu Caina Medical Co., Ltd; the summary states differences were assessed as raising no new questions of safety or effectiveness. The public record does not include the underlying test data or a detailed comparison of the changed features.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- General Hospital
- Decision date
- Sep 18, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K254095
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Martech Medical Products
- Product code
- PTI
- Decision code
- SESE
- Decision date
- Sep 18, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Non-Coring (Huber) Needle.
- Applicant
- Martech Medical Products
- Product code
- PTI
- FDA device class
- 2
FDA decision timeline
K254095 received
Application receipt date recorded by FDA.
K254095 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
No additional submissions with a verified PMA or product-code relationship are linked here.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Martech Medical Products
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Harleysville, PA
Sources and methodology
- Original FDA record: K254095
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records